Scott A. Canute

Insider Reports History

Entity
Individual
Location
Flexion Therapeutics, Inc., 10 Mall Road, Suite 301, Burlington, MA
Signature
/s/ Brian J. Shea, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Scott A. Canute:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Oncorus, Inc. Director Stock Option (right to buy) 12.5K Jun 23, 2022 Direct
Flexion Therapeutics Inc Director Common Stock 0 $8.50 Nov 19, 2021 Direct
Flexion Therapeutics Inc Director Stock option (right to buy) 0 Nov 19, 2021 Direct

Insider Reports Filed by Scott A. Canute

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ONCR Oncorus, Inc. Jun 23, 2022 1 $0 4 Jun 24, 2022 Director
FLXN Flexion Therapeutics Inc Nov 19, 2021 9 -$76.5K 4 Nov 19, 2021 Director
FLXN Flexion Therapeutics Inc Jun 24, 2021 2 $0 4 Jun 28, 2021 Director
ONCR Oncorus, Inc. Jun 16, 2021 1 $0 4 Jun 17, 2021 Director
ONCR Oncorus, Inc. Dec 11, 2020 1 $0 4/A Jun 17, 2021 Director